308 related articles for article (PubMed ID: 28488260)
1. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
Robinson CA; Huber L; Murer C; Schuurmans M; Kohler M; Hofbauer G; Benden C
Swiss Med Wkly; 2017; 147():w14429. PubMed ID: 28488260
[TBL] [Abstract][Full Text] [Related]
2. Lung transplant recipients on long-term extracorporeal photopheresis.
Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
Greer M; Dierich M; De Wall C; Suhling H; Rademacher J; Welte T; Haverich A; Warnecke G; Ivanyi P; Buchholz S; Gottlieb J; Fuehner T
Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
[TBL] [Abstract][Full Text] [Related]
4. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
[TBL] [Abstract][Full Text] [Related]
5. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
Karnes HE; Schindler EI; Morrell M; Hachem RR; Berman K; Vedantham S; Atkinson J; Spitznagel E; Despotis GJ
Transplantation; 2019 May; 103(5):1036-1042. PubMed ID: 30130331
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
Fisher AJ; White M; Goudie N; Kershaw A; Phillipson J; Bardgett M; Lally J; Bevin-Nicholls A; Chadwick T; Bryant A; Russell S; Smith H; Frisby L; Errington R; Carby M; Thompson R; Santhanakrishnan K; Parmar J; Lordan JL; Vale L; Hancock H; Exley C; Gennery AR; Wason JM
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724453
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
[TBL] [Abstract][Full Text] [Related]
11. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
; Hage CA; Klesney-Tait J; Wille K; Arcasoy S; Yung G; Hertz M; Chan KM; Morrell M; Goldberg H; Vedantham S; Derfler MC; Commean P; Berman K; Spitznagel E; Atkinson J; Despotis G
Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
[TBL] [Abstract][Full Text] [Related]
14. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
Baskaran G; Tiriveedhi V; Ramachandran S; Aloush A; Grossman B; Hachem R; Mohanakumar T
J Heart Lung Transplant; 2014 Sep; 33(9):950-6. PubMed ID: 24906794
[TBL] [Abstract][Full Text] [Related]
16. Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction.
Moniodis A; Townsend K; Rabin A; Aloum O; Stempel J; Burkett P; Camp P; Divo M; El-Chemaly S; Mallidi H; Rosas I; Fuhlbrigge A; Koo S; Goldberg HJ
J Heart Lung Transplant; 2018 Mar; 37(3):340-348. PubMed ID: 28431983
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
[TBL] [Abstract][Full Text] [Related]
18. A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction.
Benazzo A; Bagnera C; Ius F; Del Fante C; Gottlieb J; Hoetzenecker K; Meloni F; Jaksch P; Greer M
Transpl Int; 2023; 36():11551. PubMed ID: 38282747
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Hachem R; Corris P
Transplantation; 2018 Jul; 102(7):1059-1065. PubMed ID: 29557913
[TBL] [Abstract][Full Text] [Related]
20. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
